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Abstract
Defects in neutrophil function have been implicated in a wide spectrum of clinical condi-
tions. Several models are employed to study activated human neutrophils akin to those
found at a site of inflammation. These include whole blood (WB) ex vivo stimulation with
lipopolysaccharide (LPS) and in vivo techniques: cantharidin blister, skin windows and
intra-dermal injection of UV-killed E.coli (UVKEc). Neutrophils obtained from these have
never been compared. We compared the activation status of neutrophils from each tech-
nique in order to inform the optimal model for use in human studies. Healthy male volun-
teers were randomised to undergo one of the four techniques (n = 5/group). LPS: WB
stimulated with 1ng/ml of LPS for 4 hours. Cantharidin: 12.5μl of 0.1% cantharidin elicited a
single blister, aspirated at 24 hours. Skin windows: four 6mm mechanical-suction blisters
created, de-roofed and an exudate-collection chamber placed over the windows for 4 hours
before aspiration. UVKEc: 1.5 x 107 UVKEc injected intra-dermally. A single 10mm
mechanical-suction blister formed and aspirated at 4 hours. Unstimulated WB used as the
control. Flow cytometry was used to determine activation status using CD16, CD11b,
CD54, CD62L and CD88. Functional status was assessed with a phagocytosis assay. The
pattern of neutrophil activation was similar in all models. Neutrophil CD11b was elevated in
all models, most markedly in UVKEc (p<0.0001), and CD54 was also elevated but only sig-
nificant in the LPS model (p = 0.001). CD62L was significantly reduced in all 4 models
(p<0.0001) and CD88 was also suppressed in all. There were no changes in CD16 in any
model, neither was there any significant difference in the phagocytic capacity of the neutro-
phils. In summary, there are no significant differences in activation marker expression
or phagocytic capacity in the neutrophils obtained from each technique. Therefore we
believe whole blood stimulation is the best model in experimentally challenging inpatient
populations.
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Introduction
Neutrophils play a vital role in the innate immune system, the human body’s first line of
defence from infection and tissue injury. Defects in neutrophil function have been implicated
in a wide range of diseases, from congenital syndromes such as Chronic Granulomatous Dis-
ease [1] through to acquired defects in an array of conditions including Chronic Obstructive
PulmonaryDisease [2], Crohn’s disease [3], Sepsis [4], Acute Alcoholic Hepatitis [5], and Cir-
rhotic Liver Disease [6].
Traditionally, human neutrophil function has been investigated ex vivo following isolation
from fresh blood. This allows for large numbers of cells to be harvested and a wide array of
phenotypic and functional studies to be performed for each study participant. However, circu-
lating neutrophils have been shown to have significantly different characteristics to those
found at inflammatory sites or organs. For example, compared to circulating, inflammatory
site neutrophils have altered expression of cell-surface proteins including shedding of L-selec-
tin (CD62L) and up-regulation of the constitutively-expressed integrins: LFA1 (β2 integrin
CD11a complexed with CD18) and Mac-1 (CD11b complexed with CD18) [7]. These changes
result in ‘priming’ of neutrophils, enhancing their key functions such as phagocytosis and oxi-
dative burst to improve their bactericidal ability [8,9].
Thus, obtaining primed and steady state neutrophils is vital when studying their role in
health and disease. A common and straight-forwardmethod of achieving this is to stimulate
whole-blood (WB) ex vivowith lipopolysaccharide (LPS)[10]. However, neutrophils stimulated
in this manner have not been recruited to a site of inflammation from the circulation and have
therefore not undergone the active process of tethering, rolling, adherence, and trans-migration
through the endothelium [7].
In the age of translational biomedical research, human models that allow the study of neu-
trophils obtained from an environment more akin to an inflamed extravascular compartment
are employed. Such models include the cantharidin blister [11,12] skin windows (generated by
de-roofing blisters formed by negative suction) [9,13,14] and most recently described, intra-
dermal (i.d.) injection of UV-killed E. coli (UVKEc) and subsequent blister formation over the
site of injection [15]. While these models provide a way to acquire neutrophils that best repre-
sent this activated state, they do come with a cost in terms of acceptability to volunteers.
It has not been shown whether the primed neutrophils obtained from each of these three
dermal models differ significantly from those primed by ex vivo stimulation with LPS, or
indeed from each other. This information would aid selection of the most appropriate method
for obtaining primed neutrophils for human studies.
In this paper we present data comparing the activation state of neutrophils obtained from
the three dermal models of acute inflammation compared withWB stimulation with LPS.
Employing flow cytometric analysis we demonstrate that the pattern of neutrophil cell-surface
activation markers is similar across all four models and that there is no significant difference in
the phagocytic capacity of the neutrophils obtained. Given the additional complexity of per-
forming the dermal models relative to WB stimulation with LPS, we discuss the advantages
and disadvantages of each model in detail.
Materials and Methods
Young, healthy, non-smokingmale volunteers between the ages of 18–45 were recruited.
Exclusion criteria included any history of chronic illness, allergies, recent acute illness
(<1month), vaccination within the past 3 months and regular medication (prescribed, over-
the-counter or recreational). Some volunteers were used to optimise the models used (n = 7)
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and subsequent volunteers were randomly assigned to undergo one of the four experimental
techniques (n = 5/group).
All three dermal models were performed on the ventral aspect of the non-dominant arm
after shaving and disinfecting the skin, using an aseptic technique.
The study was approved by University College London (UCL) Institutional Ethics Commit-
tee (Project IDs: 4602/002, 5051/001, 5061/001). Informed written consent was taken from all
the volunteers. All procedures were in accordance with the Helsinki Declaration of 1975, as
revised in 1983.
I.d. injection of UVKEc and blister formation
The technique for i.d. injection of UVKEc and subsequent inflammatory exudate collection via
blister formation has recently been described [15]. Briefly, 1.5 x 107 UVKEc in 100 μl saline
were injected i.d. After 4 hours, a single 10mm blister was raised over the injection site by a suc-
tion chamber connected by tubing to a negative pressure instrument (NP-4, Electronic diversi-
ties Ltd., MD, USA). After securing on the chamber, negative pressure was gradually increased
from 4 to 6–7 inches of mercury and kept at 37°C until the blisters had formed (approximately
60–90 minutes). The blister was aspirated and the exudate centrifuged at 500g for 5 minutes at
10°C. The cell pellet was resuspended in buffer (PBS (Gibco, Grand Island, NY) + 5mmol/l glu-
cose + 0.2% BSA (Sigma, UK)) and kept on ice before being processed. The 4-hour time-point
was selected as this has been shown to represent the peak of neutrophil influx and TNFα pro-
duction within the model [15].
Cantharidin Blister
The technique for inducing the cantharidin skin blister has previously been described [12].
Briefly, a single blister was elicited by applying 12.5 μl of 0.1% cantharidin (Cantharone, Dor-
mer Laboratories). The blister was aspirated at 24 hours and the exudate centrifuged at 500g
for 5 minutes at 10°C. The cell pellet was resuspended in buffer and kept on ice before being
processed.
Skin Windows and Exudate Collecting Chamber (ECC)
We employed a modified version of the skin-window technique previously described [13] (Fig
1A). This was optimised by investigating the effect of modifying the key variables (Fig 1B).We
found that 50% serum encouraged neutrophil migration but that PBS, plasma and heat-treated
serumdid not (cell-count<10,000 cells in each).We trialled two time-points: 4 and 6 hours.
Although it appeared that more cells were present at 6 hours, it was less well tolerated by sub-
jects and the cell numbers at 4 hours were sufficient for the assays we employed. 8mm blisters
did not confer any benefit over 6mm blisters. Therefore, the 6mm blister and 4-hour time-
point were selected for use in the study protocol.
In the final protocol, four 6mm diameter blisters were simultaneously raised by applying a
suction chamber as described above. After the blisters had formed they were de-roofed with
sterile scissors. A novel one-use silicon ECC (MED-6015 Optically Clear Low Consistency Sili-
cone Elastomer from Polymer Systems Technology Ltd, UK) manufactured from a 3D-printed
mould was fitted over the four skin windows and held in-place by a bespoke strap. The cham-
bers were each injected with 1ml of 50% autologous serum in PBS and left in place for 4 hours
before being removed and the exudate aspirated. The serum from the 4 chambers was pooled
and centrifuged at 500g for 5 minutes at 10°C. The cell pellet was resuspended in buffer and
kept on ice before being processed.
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Fresh Whole Blood (WB)
Fresh, unstimulatedWB was used as the control for all studies. Venous WB was collected in
lithium heparin containing tubes (LH, Grenier Bio-One Vacuette). 1ml was lysed with 10ml
ACK lysis buffer before being centrifuged at 500g for 5 minutes at 10°C. The cell pellet was
resuspended in buffer and kept on ice before being processed.
WB stimulation with LPS
WB stimulation with LPS has previously been described [16]. Briefly, venousWB was collected
in lithium heparin containing tubes prior to stimulation. 1ml of WB was diluted 1:5 in RPMI
(Gibco, Grand Island, NY) in 15ml polypropylene tubes (Fisher Scientific,Grand Island, NY)
and stimulated with 1ng/ml of LPS (Salmonella abortus equi S-form [TLRgrade], Enzo Life Sci-
ences, Farmingdale, NY), within 30 minutes of draw, for 4 hours (37°C, 250rpm). After incuba-
tion, samples were centrifuged at 2000g for 10 min at 20°C. The supernatant was removed and
the remaining pellet lysed with 2ml ACK lysis buffer (Lonza, Basel, Switzerland) prior to
Fig 1. The Exudate Collecting Chamber (ECC) Model. (A) The technique employed in the ECC Model: 1&2: Blisters were formed by mechanical
suction. 3: Formed blisters. 4: Blisters de-roofed to create skin windows. 5: Silicon ‘Exudate Collecting Chamber’. 6: ECC positioned over skin
windows and kept in place by specially designed strap. 7: 50% serum introduced into chamber and then sealed with plugs. (B) Cell counts per ECC
chamber achieved with different conditions during model optimisation (50% autologous serum used throughout). Mean ± SD displayed.
doi:10.1371/journal.pone.0165502.g001
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centrifugation at 500g for 5 minutes at 10°C. The cell pellet was resuspended in buffer and kept
on ice before being processed.
Blood samples treated in an identical manner, without the addition of LPS, were used as an
additional paired-control for these studies (4-Hr WB).
Numerating cells
Cells from the three dermal blister models were enumerated using a haemocytometerwith try-
pan blue exclusion. Cells from ACK-lysed whole bloodwere enumerated using the Countess
Automated Cell Counter (Invitrogen).
Flow cytometric analysis of lineage and cell-surface markers
Flow cytometrywas used to determine the activation state of neutrophils fromWB or the der-
mal models. This panel was based on activation markers previously used for neutrophils in
bronchoalveolar lavage (BAL) fluid [17]. Cells were incubated with Human Trustain FcX (Fc
Receptor Blocking Solution) (Biolegend, UK) for the prevention of non-specific antibody bind-
ing and were stained for cellular activation using anti-human CD16 (APC), CD11b
(PerCP-Cy5.5), CD54 (FITC), CD62L (BV421) and CD88 (PE/Cy7) (all Biolegend, UK).
Cells were analysed using LSR Fortessa (BD Biosciences) with 4 lasers (Violet (405nm), Blue
(488), Green (561nm), Red (640nm)). Gating for data acquisition was performed using BD
FACSDiva 8.0.1. Flow cytometry data were analysed using FlowJo v10.0.7 (Tree Star, Inc.).
Gating strategy is described in Fig 2. Results are expressed as a percentage of single cells and/or
as geometricmean fluorescence intensity (MFI).
Phagocytosis assay
Phagocytosis assays utilising flurochrome-labelled BioParticles have been previously described
[19] however we employed a modified technique, which allowed substantially smaller numbers
of cells to be used.
Approximately 1x107 (33μg)/well Escherichia coli BioParticlues conjugated to Alexa Flour
488 (Molecular probes, Inc. Eugene, OR) were plated in 96 well plates (Costar, Corning Inter-
national, CorningNY) and were opsonised with 50% autologous serum for 30 minutes at 37°C.
After 30 minutes they were centrifuged at 3000g for 3 minutes, washed with PBS, centrifuged
again before being resuspended in 30μl buffer and kept on ice.
5x105 cells obtained from the exudates of the dermal techniques or from lysed whole blood
were plated in a separate 96 well plate. The plate was centrifuged at 700g for 3 minutes and the
cells resuspended in 30μl buffer.
Plates were then placed in an incubator for 15 minutes at 37°C. Subsequently the BioParti-
cles were mixed with the cells using a multi-channel pipette. At time 0, the first of the two wells
was aspirated and mixed with 60μl of 1% paraformaldehyde (Fisher ScientificUK) on ice, in a
third 96-well plate, to prevent any phagocytosis from occurring (negative control). The plate
was then incubated for 15 minutes at 37°C. After 15 minutes the second well was aspirated and
mixed with 60μl of 1% formaldehyde on ice to stop phagocytosis.
The plate was centrifuged at 700g for 3 minutes; the cell pellet was washed in PBS, centri-
fuged again before being resuspended in 150μl of 0.5% formaldehyde on ice. The samples were
analysed with the LSR fortessa, within 2 hours of completing the assay. Immediately prior to
being run through the flow cytometer, the samples were quenched with 150μl 0.4mg/ml Try-
pan Blue (Sigma UK).
The results were expressed as the change in MFI between the 0 minute and 15 minute sam-
ples (Fig 3A). The 15-minute time-point was selected after first performing a time-course
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using neutrophils from the ECCmodel. This demonstrated a sigmoidal curve (4PL nonlinear
regression R2 = 0.9967) and the 15-minute time-point was selected as it was on the linear part
of the curve (Fig 3B). We found that neutrophils that had previously encountered UVKEc had
significantly reduced phagocytic capacity, presumably due to previous phagocytosis (Fig 3C).
Statistics
Differences between freshWB and the four models of neutrophil priming were tested for using
unpaired, one-way ANOVA with Dunnett’s multiple comparisons test (with freshWB set as
the control). The difference in mean values between the 4-hour un-stimulatedWB and 4-hour
WB stimulated with LPS was analysed with paired t tests. Statistical analysis was performed in
Prism 6 (GraphPad Software). Statistical significancewas set at P<0.05.
Results
Cell counts
The total number of cells from each of the dermal models was between 5x105 to 1x106 per vol-
unteer (Fig 4A). There was no significant difference between the number of cells harvested
from the 3 dermal models.
Fig 2. Flow Cytometry Gating Strategy Representative dot plots of flow cytometry gating strategy for activation markers (FSC, SSC, CD16-APC,
CD11b-PerCPCy5.5, CD88-PECy7, CD54-FITC, CD62L-BV421). Exclusion of debris followed by exclusion of doublets. Exclusion of lymphocytes on
FSC/SSC. Division of remaining cells by SSC and CD16 into neutrophils (SSCinter-hiCD16hi) and mononuclear cells (SSCloCD16lo-hi). Mononuclear
cells were then further subdivided by CD11b into monocytes (SSCloCD11bhi) and dendritic cells (DCs) (SSCloCD11blo). Sample shown using human
whole blood.
doi:10.1371/journal.pone.0165502.g002
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Fig 3. Phagocytosis Assay (A) Paired representative examples of flow cytometry gating strategy for phagocytosis assay using
AF488-labelled E. coli as described in Methods. Exclusion of debris followed by exclusion of doublets. Selection of neutrophils using
A Comparison of Human Neutrophils Acquired from Four Experimental Models of Inflammation
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Cell composition
The different techniques yielded significantly different cell populations (Fig 4B). Those from
the ECC and UVKEc-blisters were comprised predominantly of neutrophils, whilst cantharidin
blisters had a much higher proportion of monocytes.
Neutrophil cell-surface markers
Neutrophils were assessed for phenotypic activation using the panel of cell-surfacemarkers
described in Methods 2.7. MFI of the activation markers was compared across the different
FSC/SSC. MFI calculated on single neutrophils. (B) Time-course of ECC neutrophil phagocytosis of AF488 E. coli particles at 5-minute
intervals. Gated as in 3A. Expressed as change in MFI from baseline (time 0). (C) 5x106 UVKEc in 50% autologous serum introduced into
x2 ECC chambers and x2 chambers used as control. Phagocytosis assay performed after 4 hours of in vivo incubation.
doi:10.1371/journal.pone.0165502.g003
Fig 4. Cell Count and Composition in the Four Models (A) Total live cell count in each dermal model: ECC (4 hours, 4 chambers pooled),
cantharidin (24 hours) and UVKEc-blisters (4 hours). Mean displayed (n = 5/group). Dotted lines represent normal range of number of
leucocytes in 1ml of human blood (3-10x106/ml). (B) Percentage of total live single cells making up blister samples split into neutrophils, total
monocytes and other cells as per gating strategy in Fig 2. Mean displayed (n = 5/group).
doi:10.1371/journal.pone.0165502.g004
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techniques. Although the trend of activation relative to freshWB was similar in all 4 models of
neutrophil priming with elevated CD11b and CD54 and reduced CD62L and CD88. However
the degree of activation differed according to model used (Fig 5).
Mean MFI of CD11b was elevated in all four models, however only reached statistical signif-
icance versus freshWB in the UVKEc-blistermodel (p<0.0001) and the LPS-stimulationmodel
(p<0.05 vs freshWB and p = 0.0035 vs 4-HrWB). Changes in CD54 were less marked, with a
trend towards increased expression in all dermalmodels vs freshWB, and a significant increase in
expression in the LPS-stimulationmodel versus 4-HrWB (p = 0.001). CD62L was markedly and
statistically significantly reduced in all four models versus freshWB (p<0.0001). CD88 was also
supressed in all four models, reaching statistical significance in the cantharidin (p<0.001) and
UVKEcmodels (p<0.01) versus freshWB and in the LPS model versus 4-HrWB (p = 0.0057).
There were no statistically significant changes in CD16 expression in any of the models.
Taken together, these data suggest that although the pattern of cell-surfacemarkers is simi-
lar between all 4 models, neutrophils from the UVKEcmodel are the most activated.
Neutrophil phagocytosis
There was no significant difference in the phagocytic capacity of neutrophils between the three
models of neutrophils priming relative to each other and freshWB, however there was a trend
towards those from the cantharidin blister having the greatest phagocytic capacity (Fig 6).
Compared to un-stimulated blood incubated for 4 hours, blood stimulated by LPS had a higher
phagocytic capacity (meanMFI 3236 v 1951), but this did not reach statistical significance.
Discussion
Neutrophil Activation
This is the first comparison of the activation status of primed human neutrophils obtained from
three different dermalmodels of acute inflammation and ex vivo stimulation of WB with LPS.
The pattern of neutrophil cell-surfacemarker expression relative to circulating neutrophils
was remarkably similar across all four models namely; reduced CD62L and CD88, elevated
CD11b and CD54 and unchanged CD16. The most marked and consistent change across all
models was the reduction in CD62L expression. This was anticipated, given that both the pro-
cess of endothelial trans-migration (dermal models), and stimulation with LPS, are known to
result in shedding of CD62L [18,19]. Shedding of CD62L plays a key role in regulating neutro-
phil migration as the resulting soluble ectodomain has a local anti-inflammatory effect [18].
The reduction in CD88 (C5a receptor) expression was also consistent, but more variable.
Previous studies have shown that neutrophil priming, by stimulation with TNFα [20] or by
non-inflammatory trans-migration to the lung [17], is associated with down-regulation of
CD88. This was most marked in the cantharidin model–possibly due to the later time-point
employed.
CD11b (Integrin alpha M) is part of the Mac-1 integrin that mediates adherence to the
endothelium. Its expression is well-recognisedmarker of neutrophil activation [21]. Our data
showed that this was elevated in all 4 models, but particularly high in the UVKEc-blister
model. This may correlate with the amount of pro-inflammatory cytokines generated in each
model. TNFα levels in the UVKEc-blistermodel have be measured at 1000pg/ml [15], whereas
the levels in the cantharidin blister (70pg/ml) [12] and skin-windowmodels (approx. 10pg/ml)
[14] are considerably less.
The trend towards increased CD54 (ICAM) expression, did not reach statistical significance
in any of the dermal models but modest rises in its expression in trans-migrated neutrophils is
in keeping with previous reports [17].
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Fig 5. Neutrophil Cell-Surface Markers MFI of neutrophil cell-surface markers compared across the different techniques.
Mean +SD displayed (n = 5/group). One-way ANOVA with Dunnett’s multiple comparisons test performed across the groups
(excluding 4-Hr WB): *p<0.5, **p<0.01, ***p<0.001. ****p<0.0001. Paired t test performed between 4-Hr WB and 4-Hr
WB + LPS: ##p<0.01 ###p<0.001.
doi:10.1371/journal.pone.0165502.g005
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The functional significance of neutrophil priming has been extensively demonstrated previ-
ously [8,9]. Our data showed a clear trend towards increased phagocytosis in the cantharidin
and LPS models, however, given the small number of subjects, this did not reach statistical
significance.
The overall pattern of cell-surfacemarker modulation observed in all four models of neutro-
phil priming is in agreement with previously published data examining the activation status of
neutrophils present in BAL fluid [17]. However, BAL is an invasive technique requiring the rele-
vant clinical training and experience.On the other hand, the models that we employed are mini-
mally invasive and can be performed safely without the specialist clinical training and facilities
required for BAL. Given that the activation pattern of neutrophils from all models were similar,
the selection of the most appropriate model for obtaining primed neutrophils should be based on
other considerations. Therefore, the major features of each of the models will now be discussed.
I.d. injection of UVKEc
We consider the i.d. injection of UVKEc to be the ‘gold standard’ inflammationmodel that we
used. It elicits the cardinal clinical signs of inflammation including redness, heat, swelling and
Fig 6. Neutrophil Phagocytosis All cells gated as shown in Fig 3A to give single neutrophils as defined by FSC &
SSC. Results expressed as change in MFI from time 0 to 15-minute time-point. Mean +SD displayed (n = 5/group).
doi:10.1371/journal.pone.0165502.g006
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pain and at the 4-hour time-point peak levels of pro-inflammatory cytokines, including TNFα,
IL-1β, IL-8 and IL-6 are observed [15]. The neutrophils trans-migrate the endothelium, are
subject to the full inflammatorymilieu and encounter bacteria. Consistent with this, the neu-
trophils appeared the most activated, with the highest expression of CD11b and suppression of
CD88.
The model also allows the full time-course of inflammation to be investigated [15]. The neg-
ative aspects of this model are that the associated pain and swelling may not be well tolerated
by some subjects (particularly unwell patients) and neutrophil exposure to UVKEc renders the
phagocytosis assay uninterpretable.
ECC and Cantharidin
Whereas the ECCmodel produces a cellular profile very similar to that of the i.d. UVKEc
model at the same time-point (4 hours), the profile obtained from the cantharidin blisters is
significantly different with a large number of monocytes and lymphocytes [12]. This difference
reflects the stage of inflammation, with the 24-hour time-point used in cantharidin represent-
ing the monocyte-driven resolution phase.
Neither of these models result in the cardinal clinical signs of inflammation as both are
driven by superficial, local tissue damage and activation of neutrophils in these models is not
augmented by additional stimulation (e.g. LPS or bacteria).
Although the pattern of activation markers was very similar between the two models, the
phagocytosis data suggests that the neutrophils from cantharidin are functionallymore active.
This may be a result of the infiltratingmonocytes present in the cantharidin blister contribut-
ing to the inflammatorymilieu by producing TNFα as well as other pro-inflammatory
cytokines.
Both models have previously been used to investigate functional defects in neutrophils. For
example, Tritto et al demonstrated neutrophil phagocytic dysfunction in patients with cirrhotic
liver disease using a version of the ECCmodel [22] and Harbord et al used cantharidin blisters
to investigate defects in neutrophil trafficking and chemotaxis in patients with Crohn’s disease
[3].
A potential unique feature of the ECCmodel is the ability to modify the fluid that is intro-
duced into the four chambers. For example, inflammatory stimulants such as LPS or UVKEc,
or pharmacological agents may be added to investigate the effect of these on neutrophil activa-
tion in vivowithout significant systemic absorption and side effects. In contrast, cantharidin
cannot be modified, but is a far simpler model to use and is well tolerated by the majority of
subjects. Given the cellular profile and time-point the model lends itself to investigating the res-
olution of inflammation and allows the study of monocytes as well as neutrophils. It is also
worth considering that cantharidin acts as a protein phosphatase 1 [23] and 2A inhibitor [24].
This may have unforeseen downstream effects on the acute inflammatory response particular
to this method of eliciting blisters and their cellular content.
WB Stimulation with LPS
Although this model is represents the least physiological means of obtaining primed neutro-
phils, the data suggests a similar phenotypic picture to dermal models.
This model has several obvious advantages. Firstly, the number of cells that can be obtained
is substantially higher, meaning more functional assays can be performed. Secondly, taking
blood is straightforward, quick and well tolerated by subjects whereas all the other models are
more complex and incompatible with acutely unwell patients. Thirdly, other inflammatory
cells aside from neutrophils can be studied, and the release of pro-inflammatory cytokines can
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be used as a proxy read-out for immune function [16]. These features explain why the model
has been used far more extensively than the dermal models to study neutrophils in the acutely
unwell patients.
Limitations
The study was limited by several factors. Firstly, there were a limited number of healthy sub-
jects enrolled in each group [5]. Although in total, 27 subjects were involved in the study,
recruitment was a challenge. Even to healthy volunteers, the dermal models are a relatively
invasive process. The low numbers had a particular impact on the phagocytosis data, as clear
trends between groups did not reach statistical significance.A wide range of potential assays is
available for testing the function of neutrophils, both in terms of migration and in terms of
phagocytosis and pathogen killing. These include studying respiratory burst, chemotaxis, che-
mokinesis and bacterial killing assays. We only employed a single assay of neutrophil function
due to the low cell numbers obtained in the blister models. Had it been possible to include
more subjects, other assays as mentioned above would have been of interest and may have elu-
cidated subtle differences between the neutrophils in the models used.
Conclusions
We have compared the activation and function of human neutrophils in 3 dermal models of
acute inflammation and contrasted this with ex vivo stimulation of WB with LPS. Our data sug-
gests that the degree of activation in each model is very similar and that all are valid means of
obtaining primed neutrophils.
Given this, the choice of model for human studies should take into account the associated
advantages and limitations of each. Factors such as cell yield and composition, ease of use and
subject tolerability should be considered.
None of the dermal techniques are compatible with the environment of an acute hospital.
Alongside this, the intradermal injection of UVKEcmay trigger unforeseen complications in a
population known to have significant immune dysfunction [25]. Therefore on balance, due to
its high cell yields, ease of performance and tolerability to patients, ex vivo stimulation of WB
with LPS is the best option for studying activated neutrophils in acutely unwell, hospitalised
inpatients.
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